These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9545022)

  • 61. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
    Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
    J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats.
    Seeley RJ; van Dijk G; Campfield LA; Smith FJ; Burn P; Nelligan JA; Bell SM; Baskin DG; Woods SC; Schwartz MW
    Horm Metab Res; 1996 Dec; 28(12):664-8. PubMed ID: 9013738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition.
    Schusdziarra V; Zimmermann JP; Schick RR
    Obes Res; 2004 Apr; 12(4):627-32. PubMed ID: 15090630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Eur J Pharmacol; 2002 Apr; 440(2-3):269-79. PubMed ID: 12007541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
    Chan SW; Lin G; Yew DT; Rudd JA
    Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
    Burmeister MA; Ayala J; Drucker DJ; Ayala JE
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.
    Nogueiras R; Pérez-Tilve D; Veyrat-Durebex C; Morgan DA; Varela L; Haynes WG; Patterson JT; Disse E; Pfluger PT; López M; Woods SC; DiMarchi R; Diéguez C; Rahmouni K; Rohner-Jeanrenaud F; Tschöp MH
    J Neurosci; 2009 May; 29(18):5916-25. PubMed ID: 19420258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
    Smith GC; Vickers MH; Cognard E; Shepherd PR
    Schizophr Res; 2009 Nov; 115(1):30-40. PubMed ID: 19679451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
    Tang-Christensen M; Vrang N; Larsen PJ
    Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Central administration of GLP-1 and GIP decreases feeding in mice.
    NamKoong C; Kim MS; Jang BT; Lee YH; Cho YM; Choi HJ
    Biochem Biophys Res Commun; 2017 Aug; 490(2):247-252. PubMed ID: 28610922
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.
    Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP
    Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of various N-terminal fragments of glucagon-like peptide-1(7-36) on food intake in the neonatal chick.
    Furuse M; Bungo T; Shimojo M; Masuda Y; Saito N; Hasegawa S; Sugahara K
    Brain Res; 1998 Oct; 807(1-2):214-7. PubMed ID: 9757042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
    Baggio LL; Kim JG; Drucker DJ
    Diabetes; 2004 Dec; 53 Suppl 3():S205-14. PubMed ID: 15561912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
    Jehle PM; Jehle D; Fussgänger RD; Adler G
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
    Perry T; Haughey NJ; Mattson MP; Egan JM; Greig NH
    J Pharmacol Exp Ther; 2002 Sep; 302(3):881-8. PubMed ID: 12183643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
    Green BD; Mooney MH; Gault VA; Irwin N; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Metabolism; 2004 Feb; 53(2):252-9. PubMed ID: 14767880
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
    Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
    Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.